Literature DB >> 1391472

PEG-bovine hemoglobin: safety in a canine dehydrated hypovolemic-hemorrhagic shock model.

K Nho1, D Glower, S Bredehoeft, H Shankar, R Shorr, A Abuchowski.   

Abstract

An initial evaluation of PEG-bHb was performed using a modified hypovolemic shock model. PEG-bHb had a substantially longer intravascular half-life than native Hb and no measurable hemoglobinuria was observed in the canine. PEG-bHb allowed successful resuscitation with an oxygen carrying capacity of 14-22% over that of lactated Ringer's solution.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1391472     DOI: 10.3109/10731199209119677

Source DB:  PubMed          Journal:  Biomater Artif Cells Immobilization Biotechnol        ISSN: 1055-7172


  11 in total

1.  Early treatment of transient focal cerebral ischemia with bovine PEGylated carboxy hemoglobin transfusion.

Authors:  Judith A Klaus; Kathleen K Kibler; Abraham Abuchowski; Raymond C Koehler
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2010-10

2.  Effects of recombinant human hemoglobin on opossum sphincter of Oddi motor function in vivo and in vitro.

Authors:  J J Cullen; J L Conklin; J Murray; A Ledlow; G Rosenthal
Journal:  Dig Dis Sci       Date:  1996-02       Impact factor: 3.199

Review 3.  Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids.

Authors:  Pedro Cabrales; Marcos Intaglietta
Journal:  ASAIO J       Date:  2013 Jul-Aug       Impact factor: 2.872

Review 4.  Oxidative pathways in the sickle cell and beyond.

Authors:  Abdu I Alayash
Journal:  Blood Cells Mol Dis       Date:  2017-05-20       Impact factor: 3.039

5.  Transfusion of hemoglobin-based oxygen carriers in the carboxy state is beneficial during transient focal cerebral ischemia.

Authors:  Jian Zhang; Suyi Cao; Herman Kwansa; Daina Crafa; Kathleen K Kibler; Raymond C Koehler
Journal:  J Appl Physiol (1985)       Date:  2012-10-04

6.  PEGylation of αα-Hb using succinimidyl propionic acid PEG 5K: Conjugation chemistry and PEG shell structure dictate respectively the oxygen affinity and resuscitation fluid like properties of PEG αα-Hbs.

Authors:  Fantao Meng; Amy G Tsai; Marcos Intaglietta; Seetharama A Acharya
Journal:  Artif Cells Nanomed Biotechnol       Date:  2014-03-06       Impact factor: 5.678

Review 7.  Hemoglobin-Based Blood Substitutes and the Treatment of Sickle Cell Disease: More Harm than Help?

Authors:  Abdu I Alayash
Journal:  Biomolecules       Date:  2017-01-04

Review 8.  Comparison of the Pharmacokinetic Properties of Hemoglobin-Based Oxygen Carriers.

Authors:  Kazuaki Taguchi; Keishi Yamasaki; Toru Maruyama; Masaki Otagiri
Journal:  J Funct Biomater       Date:  2017-03-18

Review 9.  Nanomedicines: A Potential Treatment for Blood Disorder Diseases.

Authors:  Nan Zhang; Ming-Yuan Wei; Qiang Ma
Journal:  Front Bioeng Biotechnol       Date:  2019-11-28

10.  Mechanisms of Toxicity and Modulation of Hemoglobin-based Oxygen Carriers.

Authors:  Abdu I Alayash
Journal:  Shock       Date:  2019-10       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.